Antithyroid Drugs

To the Editor: In his review of antithyroid drugs (March 3 issue), 1 Cooper does not mention the potential advantage of combined treatment with antithyroid drugs and thyroxine (referred to as the “block–replace regimen”). Even if such a regimen has not been demonstrated to be superior in terms of de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2005-05, Vol.352 (21), p.2246-2247
Hauptverfasser: Goichot, Bernard, Vinzio, Stephane
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To the Editor: In his review of antithyroid drugs (March 3 issue), 1 Cooper does not mention the potential advantage of combined treatment with antithyroid drugs and thyroxine (referred to as the “block–replace regimen”). Even if such a regimen has not been demonstrated to be superior in terms of definitive cure, for many clinicians it is a simpler and faster way to achieve euthyroidism in most patients with Graves' disease than is treatment with methimazole alone. High doses of methimazole may be associated with more minor side effects, but in controlled studies the doses used ranged from 30 to 60 mg . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM200505263522120